Invacare 2012 Annual Report Download - page 49

The following table presents information with respect to repurchases of common shares made by the
company during the three months ended December 31, 2012.
Period
Total Number of
Shares
Purchased (1)
Average Price
Paid Per Share
Total Number of Shares
Purchased as Part of
Publicly Announced
Plans or Programs
Maximum Number
of Shares That May Yet
Be Purchased Under
the Plans or Programs (2)
10/1/2012 - 10/31/12 .... — $ — — 2,453,978
11/1/2012 - 11/30/12 .... 26,776 13.02 — 2,453,978
12/1/2012 - 12/31/12 .... — — — 2,453,978
Total .................. 26,776 $ 21.20 — 2,453,978
(1) All 26,776 shares repurchased between November 1, 2012 and November 30, 2012 were surrendered to
the company by employees for minimum tax withholding purposes in conjunction with the vesting of
restricted shares awarded to the employees under the company’s 2003 Performance Plan.
(2) In 2001, the Board of Directors authorized the company to purchase up to 2,000,000 Common Shares,
excluding any shares acquired from employees or directors as a result of the exercise of options or vesting
of restricted shares pursuant to the company’s performance plans. The Board of Directors reaffirmed its
authorization of this repurchase program on November 5, 2010, and on August 17, 2011 authorized an
additional 2,046,500 shares for repurchase under the plan. To date, the company has purchased
1,592,522 shares under this program, with authorization remaining to purchase 2,453,978 shares. The
company did not purchased any shares pursuant to this Board authorized program during 2012.
During 2012, the company purchased a total of $500,000 in principal amount of its outstanding 4.125%
Convertible Senior Subordinated Debentures due 2027 in privately negotiated transactions for an aggregate of
approximately $501,000, plus accrued and unpaid interest. The company may continue from time to time seek to
retire or purchase the company’s outstanding 4.125% Convertible Senior Subordinated Debentures due 2027, in
privately negotiated transactions or otherwise.
The equity compensation plan information required under Item 201(d) of Regulation S-K is incorporated by
reference to the information under the caption “Equity Compensation Plan Information” in the company’s
definitive Proxy Statement on Schedule 14A for the 2013 Annual Meeting of Shareholders.
Item 6. Selected Financial Data.
The selected consolidated financial data set forth below with respect to the company’s consolidated
statements of comprehensive income (loss), cash flows and shareholders’ equity for the fiscal years ended
December 31, 2012, 2011 and 2010, and the consolidated balance sheets as of December 31, 2012 and 2011 are
derived from the Consolidated Financial Statements included elsewhere in this Form 10-K. The consolidated
statements of comprehensive income (loss), cash flows and shareholders’ equity data for the fiscal years ended
December 31, 2009 and 2008 and consolidated balance sheet data for the fiscal years ended December 31, 2010,
2009 and 2008 are derived from the company’s previously filed Consolidated Financial Statements. The data set
forth below should be read in conjunction with Item 7—“Management’s Discussion and Analysis of Financial
Condition and Results of Operations” and the company’s Consolidated Financial Statements and Notes thereto
included elsewhere in this Form 10-K. On December 21, 2012, the company entered into an agreement to dispose
of its Invacare Supply Group (ISG) business. As such, the results of operations for this business have been
I-43